Why the study?
Does Roux-en-Y gastric bypass reduce antihypertensive medication use or induce hypertension remission in obese individuals with controlled hypertension?
Does Roux-en-Y gastric bypass reduce antihypertensive medication use or induce hypertension remission in obese individuals with controlled hypertension?
Answers are grounded in this paper and cite their sources.
Roux-en-Y gastric bypass is an effective treatment for hypertension in obese patients, leading to significant reduction or cessation of antihypertensive medications.
Jesper Bäckdahl is a resident in Endocrinology and PhD student under the supervision of Mikael Rydén. Dr Bäckdahl holds a master degree in Public Health from the London School of Hygiene and Tropical Medicine. His research revolves around adipose tissue and its link to arterial stiffness and hypertension. Mikael Rydén is a senior consultant in Endocrinology, Diabetology and Internal Medicine and Professor of Clinical and Experimental Adipose Tissue Research. Prof Rydén has over 20 years of experience in the research file spanning over experimental and clinical studies with a particular focus on the links between adipocytes and cardiometabolic complications. He has published almost 200 peer-reviewed original articles and reviews and has been engaged in several regulatory authorities setting up guidelines for type 2 diabetes treatment. While there is much observational evidence that weight loss and bariatric surgery lead to a sustained reduction in blood pressure,1,2 until the Gastric Bypass to Treat Obese Patients With Steady Hypertension (GATEWAY) trial, there has been no randomized bariatric surgery study in hypertensive subjects where hypertension remission and/or reduction of antihypertensive medications were used as primary outcomes.3 The GATEWAY trial prospectively randomized 100 obese individuals with established but controlled hypertension to either Roux-en-Y gastric bypass (RYGB) or conventional medical therapy. At the 12-month follow-up >80% of the subjects in the surgery group had been able to stop or reduce their antihypertensive medication compared with only ∼13% in the medication group. This conclusively shows that RYGB surgery is an effective treatment of hypertension.
No takes yet. Share an insight, caveat, or question.
Bäckdahl et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: